The effects of esmolol and magnesium on blood glucose regulation in the patients with type II diabetes mellitus undergoing CABG surgery;Koroner arter cerrahisi planlanan tip II diyabetes mellitus olgularinda esmolol ve magnezyumun kan şekeri regülasyonuna etkisi

Gogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisi

Volumn 12, Issue 4, 2006, Pages 143-148

  But, A Kadir ^a   Yapici, Engin ^a   Erdil, Feray ^a   Öztürk, Erdoǧan ^a   Gedik, Ender ^a   Durmus, Mahmut ^a   Ersoy, M Özcan ^a  

^a Patoloji Anabilim Dali   (Turkey)

Author keywords

Coronary bypass surgery; Esmolol; Magnesium; Type II diabetes mellitus

Indexed keywords

ARITMAL; ESMOLOL; FENTANYL; FENTANYL CITRATE; GLUCOSE; INSULIN; LIDOCAINE; MAGNESIUM SULFATE; MIDAZOLAM; MIDAZOLAM MALEATE; PROTAMINE; UNCLASSIFIED DRUG; VECURONIUM;

ANESTHESIA INDUCTION; ARTICLE; BLOOD GLUCOSE MONITORING; CANNULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG INFUSION; ELECTIVE SURGERY; GLUCOSE BLOOD LEVEL; HUMAN; INTRAOPERATIVE PERIOD; NON INSULIN DEPENDENT DIABETES MELLITUS; OPERATING ROOM; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT;

EID: 33847632132     PISSN: 13055550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. McAlister FA, Man J, Bistritz L, et al: Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care 26:1518, 2003.
2. Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA 23; 293:1501, 2005.
3. Ghali WA, Quan H, Brant R: Coronary artery bypass grafting in Canada: national and provincial mortality trends, 1992-1995. Can Med Assoc J 159:25, 1998.
4. Lazar HL, Chipkin SL, Fitzgerald CA, et al: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation 109:1497, 2004.
5. Bothe W, Olschewski M, Beyersdorf F, Doenst T: Glucose-insulin-potassium in cardiac surgery: a meta-analysis. Ann Thorac Surg 78:1650, 2004.
6. Smith A, Grattan A, Harper M, et al: Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. J Cardiothorac Vasc Anesth 16:413, 2002.
7. Carvalho G, Moore A, Qizilbash B, et al: Maintenance of normoglycemia during cardiac surgery. Anesth Analg 99:319, 2004.
8. Miriam A, Korula G: A simple glucose insulin regimen for perioperative blood glucose control: the vellore regimen. Anesth Analg 99:598, 2004.
9. Leos CL, Griego JE, Anderson JR: Glucose-insulin-potassium therapy in the era of coronary revascularization. Cardiology in Review 13:266, 2005.
10. Pirk J, Kolar F, Ost'adal B, et al: The effect of the ultrashort beta-blocker esmolol on cardiac function recovery: an experimental study. Eur J Cardiothorac Surg 15:199, 1999.
11. Fawcett WJ, Haxby EJ, Male DA: Magnesium: physiology and pharmacology. Br J Anaesth 83:302, 1999.
12. Mangano DT, Hollenberg M, Fegert G, et al: Perioperative myocardial ischemia in patients undergoing noncardiac surgery-I: incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. J Am Coll Cardiol 17:843, 1991.
13. McCann RL, Clements FM: Silent myocardial ischemia in patients undergoing peripheral vascular surgery: incidence and association with perioperative cardiac morbidity and mortality. J Vasc Surg 9:583, 1989.
14. Gray RJ, Bateman TM, Czer LS, et al: Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias. J Am Coll Cardiol 5:1451, 1985.
15. Wahab NN, Cowden EA, Pearce NJ, et al: Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748, 2002.
16. Norhammar AM, Ryden L, Malmberg K: Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in non-diabetic patients. Diabetes Care 11:1827, 1999.
17. Iwakura K, Ito H, Ikoshima M, et al: Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1, 2003.
18. Furnary AP, Gao G, Grunkemeier GL, et al: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007, 2003.
19. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 314:1512, 1997.
20. Turlapaty P, Laddu A, Murthy VS, et al: Esmolol: a titra-table short-acting intravenous beta blocker for acute critical care settings. Am Heart J 114:866, 1987.
21. Askenazi J, MacCosbe PE, Hoff J, et al: Hemodynamic effects of esmolol, a short acting beta blocker. J Clin Pharmacol 27:567, 1987.
22. Vyvyan H, Mayne PN, Cutfield GR: Magnesium flux and cardiac surgery. A study of the relationship between magnesium exchange, serum magnesium levels and postoperative arrhythmias. Anaesthesia 49:245, 1994.
23. Gums JG: Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61:1569, 2004.
24. Bert AA, Reinert SE, Singh AK: A B-blocker, not magnesium, is effective prophylaxis for atrial tachyarrhythmias after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 15:204-9, 2001.